A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Exclusive manufacturer-reported metrics
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 616
Comprehensive Pages
- 4463
Listings of Refractive Surgeons
- 85
Metro Areas with Detailed Analysis
- 1179
Listings of LVC Centers
Latest Industry News & Trends
10/11/2018
orthopedicpress release
Market Scope Announces Launch of New Website and Entry into Orthopedics
.jpg)
Market Scope, an industry leader for ophthalmic market research, announced today the launch of its new website and the firm’s entry into orthopedics, its second medical vertical. The new Market-Sco...
11/16/2018
ophthalmicbreaking
Allergan Loses Appeal on Restasis Patents, Opening Door for Generics
.png)
The US Court of Appeals for the Federal Circuit in Washington on Nov. 13 affirmed a lower court decision invalidating the patents for Restasis. The appeals court made its ruling a week after it hea...
11/16/2018
ophthalmicbreaking
Ophthotech Drops Wet AMD Program for Zimura to Focus on Other Indications
Ophthotech has dropped its pursuit of a wet age-related macular degeneration (AMD) indication for Zimura in combination with Lucentis, the New York-based company announced Nov. 13. Zimura combinati...
11/16/2018
ophthalmicbreaking
Omeros Announces $210 Convertible Debt Offering
Omeros Corporation is looking to raise $210 million in a convertible debt offering, the Seattle-based company announced Nov. 13. The company has granted initial purchasers of the notes an option to...
11/16/2018
ophthalmicbreaking
4D Molecular Therapeutics Gains Orphan Drug Designation for Choroideremia Treatment
The US FDA has granted orphan drug designation to 4D Molecular Therapeutics’ treatment candidate for choroideremia, 4D-110, the Emeryville, California, company announced Nov. 16. 4D-110 is administ...
11/16/2018
ophthalmicbreaking
AsclepiX Raises $5 Million in Support of Candidate for DME, AMD
AsclepiX Therapeutics announced Nov. 13 that it has raised $5 million in convertible note funding. The Baltimore company said it will use the funds to develop AXT107, its treatment candidate for di...
11/16/2018
ophthalmicbreaking
RetiPharma Nets $1.48 Million to Develop Degenerative Eye Disorder Treatments
RetiPharma has secured funding from the Novo Nordisk Foundation’s BioInnovation Institute (BII) in the form of a convertible note to be paid in tranches totaling €1.3 million (about $1.48 million),...
11/16/2018
ophthalmicbreaking
Notal Vision Appoints Susan Orr as CEO
Notal Vision has appointed Susan Orr, OD, to become its next CEO, effective Jan. 1, 2019, the company announced Nov. 1. Orr will replace Quinton Oswald, who will retire at the end of 2018 but will ...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.